Cargando…

Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher’s Disease Type 3

BACKGROUND: Chronic neuronopathic Gaucher’s disease type 3 (GD3) is relatively frequent in northern Sweden. Besides multiple other neurological symptoms, horizontal gaze palsy or oculomotor apraxia is common in GD3. OBJECTIVE: To characterize the saccades in patients with Norrbottnian GD3 with respe...

Descripción completa

Detalles Bibliográficos
Autores principales: Blume, Josefine, Beniaminov, Stanislav, Kämpe Björkvall, Cecilia, Machaczka, Maciej, Svenningsson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479920/
https://www.ncbi.nlm.nih.gov/pubmed/28690585
http://dx.doi.org/10.3389/fneur.2017.00295
_version_ 1783245194237313024
author Blume, Josefine
Beniaminov, Stanislav
Kämpe Björkvall, Cecilia
Machaczka, Maciej
Svenningsson, Per
author_facet Blume, Josefine
Beniaminov, Stanislav
Kämpe Björkvall, Cecilia
Machaczka, Maciej
Svenningsson, Per
author_sort Blume, Josefine
collection PubMed
description BACKGROUND: Chronic neuronopathic Gaucher’s disease type 3 (GD3) is relatively frequent in northern Sweden. Besides multiple other neurological symptoms, horizontal gaze palsy or oculomotor apraxia is common in GD3. OBJECTIVE: To characterize the saccades in patients with Norrbottnian GD3 with respect to their neurological and cognitive status using a computer-based eye-tracking technique. METHODS: Horizontal and vertical reflexive saccades as well as antisaccades of nine GD3 patients [4M/5F; 41.1 ± 11.0 years; modified severity scoring tool (mSST): 9.3 ± 5.4; Montreal Cognitive Assessment (MoCA): 24.0 ± 4.2] and age-matched controls were analyzed using EyeBrain T2, a head-mounted binocular eye tracker. Systematic clinical assessment included the mSST, a valid tool for monitoring the neurological progression in GD3 and MoCA. RESULTS: In Norrbottnian GD3 patients, gain, peak, and average velocity (107.5°/s ± 41.8 vs. 283.9°/s ± 17.0; p = 0.0009) of horizontal saccades were reduced compared to healthy controls (HCs). Regarding vertical saccades, only the average velocity of downward saccades was decreased (128.6°/s ± 63.4 vs. 244.1°/s ± 50.8; p = 0.004). Vertical and horizontal saccadic latencies were increased (294.3 ms ± 37.0 vs. 236.5 ms ± 22.4; p = 0.005) and the latency of horizontal reflexive saccades was correlated with the mSST score (R(2) = 0.80; p = 0.003). The latency of antisaccades showed association to MoCA score (R(2) = 0.70; p = 0.009). GD3 patients made more errors in the antisaccade task (41.5 ± 27.6% vs. 5.2 ± 5.8%; p = 0.005), and the error rate tended to correlate with the cognitive function measured in MoCA score (p = 0.06). CONCLUSION: The mean age of 41 years of our GD3 cohort reflects the increased life expectancy of patients in the Norrbottnian area compared to other GD3 cohorts. Marked impairment of horizontal saccades was evident in all patients, whereas vertical saccades showed distinct impairment of downward velocity. Latency of reflexive saccades was associated with the severity of neurological symptoms. Increased latency and error rate in the antisaccade task were linked to cognitive impairment. The assessment of saccades provides markers for neurological and neuropsychological involvement in Norrbottnian GD3.
format Online
Article
Text
id pubmed-5479920
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54799202017-07-07 Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher’s Disease Type 3 Blume, Josefine Beniaminov, Stanislav Kämpe Björkvall, Cecilia Machaczka, Maciej Svenningsson, Per Front Neurol Neuroscience BACKGROUND: Chronic neuronopathic Gaucher’s disease type 3 (GD3) is relatively frequent in northern Sweden. Besides multiple other neurological symptoms, horizontal gaze palsy or oculomotor apraxia is common in GD3. OBJECTIVE: To characterize the saccades in patients with Norrbottnian GD3 with respect to their neurological and cognitive status using a computer-based eye-tracking technique. METHODS: Horizontal and vertical reflexive saccades as well as antisaccades of nine GD3 patients [4M/5F; 41.1 ± 11.0 years; modified severity scoring tool (mSST): 9.3 ± 5.4; Montreal Cognitive Assessment (MoCA): 24.0 ± 4.2] and age-matched controls were analyzed using EyeBrain T2, a head-mounted binocular eye tracker. Systematic clinical assessment included the mSST, a valid tool for monitoring the neurological progression in GD3 and MoCA. RESULTS: In Norrbottnian GD3 patients, gain, peak, and average velocity (107.5°/s ± 41.8 vs. 283.9°/s ± 17.0; p = 0.0009) of horizontal saccades were reduced compared to healthy controls (HCs). Regarding vertical saccades, only the average velocity of downward saccades was decreased (128.6°/s ± 63.4 vs. 244.1°/s ± 50.8; p = 0.004). Vertical and horizontal saccadic latencies were increased (294.3 ms ± 37.0 vs. 236.5 ms ± 22.4; p = 0.005) and the latency of horizontal reflexive saccades was correlated with the mSST score (R(2) = 0.80; p = 0.003). The latency of antisaccades showed association to MoCA score (R(2) = 0.70; p = 0.009). GD3 patients made more errors in the antisaccade task (41.5 ± 27.6% vs. 5.2 ± 5.8%; p = 0.005), and the error rate tended to correlate with the cognitive function measured in MoCA score (p = 0.06). CONCLUSION: The mean age of 41 years of our GD3 cohort reflects the increased life expectancy of patients in the Norrbottnian area compared to other GD3 cohorts. Marked impairment of horizontal saccades was evident in all patients, whereas vertical saccades showed distinct impairment of downward velocity. Latency of reflexive saccades was associated with the severity of neurological symptoms. Increased latency and error rate in the antisaccade task were linked to cognitive impairment. The assessment of saccades provides markers for neurological and neuropsychological involvement in Norrbottnian GD3. Frontiers Media S.A. 2017-06-22 /pmc/articles/PMC5479920/ /pubmed/28690585 http://dx.doi.org/10.3389/fneur.2017.00295 Text en Copyright © 2017 Blume, Beniaminov, Kämpe Björkvall, Machaczka and Svenningsson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Blume, Josefine
Beniaminov, Stanislav
Kämpe Björkvall, Cecilia
Machaczka, Maciej
Svenningsson, Per
Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher’s Disease Type 3
title Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher’s Disease Type 3
title_full Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher’s Disease Type 3
title_fullStr Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher’s Disease Type 3
title_full_unstemmed Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher’s Disease Type 3
title_short Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher’s Disease Type 3
title_sort saccadic impairments in patients with the norrbottnian form of gaucher’s disease type 3
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479920/
https://www.ncbi.nlm.nih.gov/pubmed/28690585
http://dx.doi.org/10.3389/fneur.2017.00295
work_keys_str_mv AT blumejosefine saccadicimpairmentsinpatientswiththenorrbottnianformofgauchersdiseasetype3
AT beniaminovstanislav saccadicimpairmentsinpatientswiththenorrbottnianformofgauchersdiseasetype3
AT kampebjorkvallcecilia saccadicimpairmentsinpatientswiththenorrbottnianformofgauchersdiseasetype3
AT machaczkamaciej saccadicimpairmentsinpatientswiththenorrbottnianformofgauchersdiseasetype3
AT svenningssonper saccadicimpairmentsinpatientswiththenorrbottnianformofgauchersdiseasetype3